1999
DOI: 10.1016/s0966-6362(99)00037-5
|View full text |Cite
|
Sign up to set email alerts
|

Botulinum toxin A in hamstring spasticity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
57
0

Year Published

2002
2002
2020
2020

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 98 publications
(60 citation statements)
references
References 11 publications
3
57
0
Order By: Relevance
“…Considerable data have now been gathered from many randomized and placebo-controlled studies to support the use of BTX-A for this condition [1][2][3][4][5][6][7]. Functional gains, however, have been more difficult to demonstrate [8].…”
Section: Introductionmentioning
confidence: 99%
“…Considerable data have now been gathered from many randomized and placebo-controlled studies to support the use of BTX-A for this condition [1][2][3][4][5][6][7]. Functional gains, however, have been more difficult to demonstrate [8].…”
Section: Introductionmentioning
confidence: 99%
“…Botulinum toxin A injection should be used in carefully selected patients. Corry et al (21) showed that anterior pelvic tilt increased after botulinum toxin A injection to hamstring muscles in 10 CP patients with crouch gait. Care should be taken not to cause isolated hamstring weakness.…”
Section: Management Of Knee Flexion Deformitiesmentioning
confidence: 99%
“…38,40 If this fails to correct an equinovarus deformity fully, tibialis posterior can be injected or, if more appropriate, tibialis anterior. Similarly, overactivity of the hamstrings can be improved by injection of BTX-A and the response to injection may also help to predict the results of hamstring lengthening 41 or adductor tenotomy. Injection of the hip flexors is more technically demanding and may require ultrasound guidance for the accurate localisation of the muscle, and hence the toxin.…”
Section: Cerebral Palsymentioning
confidence: 99%